Rodman & Renshaw Starts Onyx Pharmaceuticals (ONXX) at Market Outperform
Tweet Send to a FriendGet Alerts ONXX Hot Sheet
Price: $95.67 +2.84%
Rating Summary:
20 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 23 | New: 29
Rating Summary:
20 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 23 | New: 29
Trade ONXX Now!
Rodman & Renshaw initiates coverage on Onyx Pharmaceuticals (NASDAQ: ONXX) with a Market Outperform. PT $62.00.
For an analyst ratings summary and ratings history on Onyx Pharmaceuticals click here. For more ratings news on Onyx Pharmaceuticals click here.
Shares of Onyx Pharmaceuticals closed at $44.10 yesterday, with a 52 week range of $27.17-$46.07.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Onyx Pharmaceuticals click here. For more ratings news on Onyx Pharmaceuticals click here.
Shares of Onyx Pharmaceuticals closed at $44.10 yesterday, with a 52 week range of $27.17-$46.07.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Brean Capital Raises Onyx (ONXX) Price Target to $115
- Topeka Capital Starts CEVA Inc. (CEVA) at Buy
- Maxim Group Starts City National (CYN) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Rodman & Renshaw
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
